Differentiating bipolar disorder from depression in primary care

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 2, 2007, Pages 89-105

  Muzina, David J ^a   Colangelo, Elisa ^a   Manning, J Sloan ^b   Calabrese, Joseph R ^b,c,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Psychiatry ^*  (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM; TRIAZINE DERIVATIVE; VALPROIC ACID;

BIPOLAR DISORDER; DEPRESSION; DIFFERENTIAL DIAGNOSIS; GENERAL PRACTITIONER; HUMAN; MAJOR DEPRESSION; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; REVIEW;

BIPOLAR DISORDER; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; HUMANS; LITHIUM; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; TRIAZINES; VALPROIC ACID;

EID: 34047182014     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.2.89     Document Type: Review

References (24)

1. Regler DA, Narrow WE, Rae DS, Manderscheid RW, Locke BZ, Goodwin FK. The de facto US mental and addictive disorders service system: epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry 1993; 50:85-94.
2. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000.
3. Ghaemi N, Sachs GS, Goodwin FK. What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness. World J Biol Psychiatry 2000; 1:65-74.
4. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry 2000; 61(suppl 13):38-41.
5. Begley CE, Annegers JF, Swann AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001; 19:483-495.
6. Hirschfeld RM, Williams JB, Spitzer RL. et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000, 157:1873-1875.
7. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64:53-59.
8. Das AK, Olfson M, Gameroff MJ. et al. Screening for bipolar disorder in a primary care practice. JAMA 2005; 293:956-963.
9. Manning JS, Zylstra RG, Connor PD. Teaching family physicians about mood disorders: a procedure suite for behavioral medicine. Prim Care Companion J Clin Psychiatry 1999; 1:18-23.
10. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530-537.
11. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York: Oxford University Press, 1990.
12. Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ. Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 1997; 73:47-56.
13. Slama F, Bellivier F, Henry C, et al. Bipolar patients with suicidal behavior: toward the identification of a clinical subgroup. J Clin Psychiatry 2004; 65:1035-1039.
14. Muzina DJ. What physicians can do to prevent suicide. Cleve Clin J Med 2004; 71:242-250.
15. Hirschfeld RM. Lewis L. Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003; 64:161-174.
16. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31:281-294.
17. Manning JS, Haykal RF, Connor PD, Akiskal HS. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry 1997; 38:102-108.
18. Hirschfeld RM, Cass AR, Holt DC, Carlson CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract 2005; 18:233-239.
19. Ettinger AB, Reed ML, Goldberg JF, Hirschfeld RM. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 2005; 65:535-540.
20. Ghaemi SN. Mood Disorders: A Practical Guide. Philadelphia: Lippincott Williams & Wilkins, 2003.
21. Muzina DJ, Calabrese JR. Recent placebo-controlled acute trials in bipolar depression: focus on methodology. Int J Neuropsychopharmacol 2003; 6:285-291.
22. Muzina DJ, Elhaj O. Gajwani P, Gao K, Calabrese JR. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder. Acta Psychiatr Scand Suppl 2005; (426):21-28.
23. Muzina DJ, Calabrese JR. Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Aust NZ J Psychiatry 2005; 39:652-661.
24. Suppes T, Dennehy EB, Hirschfeld RM, et al; Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005; 66:870-816.